Contract development and manufacturing organization (CDMO) Wacker Biotech will manufacture active protein ingredients for MinervaX’s Group B Streptococcus (GBS) vaccine. The German-based CDMO has been ...

Bavarian Nordic has signed an agreement with Gavi, The Vaccine Alliance and its partners to supply 500,000 doses of its MVA-BN mpox vaccine to African countries by the end of 2024. The vaccines will ...

Steve McCloskey , founder and chief executive officer, Nanome McCloskey began his presentation by sharing an artificial-intelligence (AI)–generated image of the future of AI-supplemented drug ...

HTTPS://WWW.ISTOCKPHOTO.COM It’s no secret that mammalian cell culture is the predominant production system in the biopharmaceutical industry. Microbial expression has been around longer, not least ...

The firms will co-commercialize the products globally, except for MK-6070 in Japan where Merck (known as MSD outside of the US and Canada) will retain the exclusive rights. Merck will also be solely ...

With this issue, we bid a reluctant farewell to our managing editor as she retires. Cheryl and I have known her and appreciated her friendship for 26 years. Her accumulated knowledge of cell and gene ...

Founded in the middle of 2002, BPI published its first issue in January of 2003. Our 20th-anniversary issue thus takes the form of a state-of-the-early-21st-century industry report. Assembling this ...

November-December 2019 ...

Protein A has made monoclonal antibodies (MAbs) highly manufacturable and easier to develop in laboratories. Its use has enabled purification platform approaches, which have been key elements in ...